Evidence map›Paper›PMID 32556918›Full record

ArticleSleep & breathing = Schlaf & Atmung2020

Correlates of sleep quality and excessive daytime sleepiness in people with opioid use disorder receiving methadone treatment.

Stephen R Baldassarri, Mark Beitel, Andrey Zinchuk, Nancy S Redeker, David E Oberleitner, Lindsay M S Oberleitner, Danilo Carrasco, Lynn M Madden, Nathan Lipkind, David A Fiellin and 4 more

Open access · greenAbstract read
In one paragraph

Article in Sleep & breathing = Schlaf & Atmung, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Worsening sleep quality across the lifespan and persistent sleep disturbances in persons with opioid use disorder.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Stephen R BaldassarriDepartment of Internal Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, 300 Cedar Street, TAC-455 South, New Haven, CT, 06520, USA. stephen.baldassarri@yale.edu.ORCID http://orcid.org/0000-0002-5928-3733
Mark BeitelDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Andrey ZinchukDepartment of Internal Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, 300 Cedar Street, TAC-455 South, New Haven, CT, 06520, USA.
Nancy S RedekerDepartment of Internal Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, 300 Cedar Street, TAC-455 South, New Haven, CT, 06520, USA.
David E OberleitnerDepartment of Psychology, University of Bridgeport, Bridgeport, CT, USA.
Lindsay M S OberleitnerDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Danilo CarrascoDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Lynn M MaddenDepartment of Internal Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, 300 Cedar Street, TAC-455 South, New Haven, CT, 06520, USA.
Nathan LipkindAPT Foundation, New Haven, CT, USA.
David A FiellinDepartment of Internal Medicine, Section of General Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Lori A BastianDepartment of Internal Medicine, Section of General Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Kevin ChenDepartment of Internal Medicine, Section of General Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
H Klar YaggiDepartment of Internal Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, 300 Cedar Street, TAC-455 South, New Haven, CT, 06520, USA.
Declan T BarryDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Yale University · USAPT Foundation · USUniversity of Bridgeport · USWestern Connecticut State University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Understanding Factors that Influence Electronic Cigarette Nicotine Delivery Through PET Imaging of Beta-2 Nicotinic Acetylcholine ReceptorsK23DA045957 · NIDA · YALE UNIVERSITY · PI BALDASSARRI, STEPHEN · 2018 to 2022
$983k
Chronic Pain and Opioid Dependence Assessment and TreatmentK23DA024050 · NIDA · YALE UNIVERSITY · PI BARRY, DECLAN T. · 2008 to 2012
$901k
Mentoring in Sleep Research and Sleep Interventions in Heart Disease, and StrokeK24HL132093 · NHLBI · YALE UNIVERSITY · PI YAGGI, HENRY KLAR · 2016 to 2020
$336k
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS K24 HL132093NIDA NIH HHS K23 DA024050NIDA NIH HHS K23 DA045957NIDA NIH HHS K23DA045957
6 · The paper itself

Abstract

purposeThe aim of this study was to evaluate the prevalence and clinical correlates of impaired sleep quality and excessive daytime sleepiness among patients receiving methadone for opioid use disorder (OUD).

methodsPatients receiving methadone (n = 164) completed surveys assessing sleep quality (Pittsburgh Sleep Quality Index [PSQI]), daytime sleepiness (Epworth Sleepiness Scale [ESS]), and related comorbidities. We used bivariate and multivariable linear regression models to evaluate correlates of sleep quality and daytime sleepiness.

resultsNinety percent of patients had poor sleep quality (PSQI >5), and the mean PSQI was high (11.0 ±4). Forty-six percent reported excessive daytime sleepiness (ESS > 10). In multivariable analyses, higher PSQI (worse sleep quality) was significantly associated with pain interference (coefficient = 0.40; 95% CI = 0.18-0.62; β = 0.31), somatization (coefficient = 2.2; 95% CI = 0.75-3.6; β = 0.26), and negatively associated with employment (coefficient = - 2.6; 95% CI = - 4.9 to - 0.19; β = - 0.17). Greater sleepiness was significantly associated with body mass index (coefficient = 0.32; 95% CI = 0.18-0.46; β = 0.33), and there was a non-significant association between sleepiness and current chronic pain (coefficient = 1.6; 95% CI = 0.26-3.5; β = 0.13; p value = 0.09).

conclusionsPoor sleep quality and excessive daytime sleepiness are common in patients receiving methadone for OUD. Chronic pain, somatization, employment status, and obesity are potentially modifiable risk factors for sleep problems for individuals maintained on methadone. People with OUD receiving methadone should be routinely and promptly evaluated and treated for sleep disorders.

Indexed as

AdultAnalgesics, OpioidDisorders of Excessive SomnolenceFemaleHumansMaleMethadoneMiddle AgedOpioid-Related DisordersSleepSurveys and QuestionnairesAnalgesics, OpioidMethadoneMethadoneOpioidPainSleepinessSleep qualitySomatization

Identifiers

PMID32556918
PMCPMC7680294
OpenAlexW3036863042

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.